Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Uncertainties in source allocation of carbonaceous aerosols in a Mediterranean region.
Navarro-Barboza H, Pandolfi M, Guevara M, Enciso S, Tena C, Via M, Yus-Díez J, Reche C, Pérez N, Alastuey A, Querol X, Jorba O. Navarro-Barboza H, et al. Among authors: tena c. Environ Int. 2024 Jan;183:108252. doi: 10.1016/j.envint.2023.108252. Epub 2023 Oct 17. Environ Int. 2024. PMID: 38157608 Free article.
An emission processing system for air quality modelling in the Mexico City metropolitan area: Evaluation and comparison of the MOBILE6.2-Mexico and MOVES-Mexico traffic emissions.
Guevara M, Tena C, Soret A, Serradell K, Guzmán D, Retama A, Camacho P, Jaimes-Palomera M, Mediavilla A. Guevara M, et al. Among authors: tena c. Sci Total Environ. 2017 Apr 15;584-585:882-900. doi: 10.1016/j.scitotenv.2017.01.135. Epub 2017 Jan 24. Sci Total Environ. 2017. PMID: 28129908
High Mortality of COVID-19 in Young Mexican Patients With Rheumatic Diseases: Comparative Analysis Versus the General Population.
Martínez-Martínez MU, Colunga-Pedraza IJ, Irazoque-Palazuelos F, Reyes-Cordero G, Rodriguez-Reyna TS, Veloz-Aranda JA, Skinner-Taylor CM, Juárez-Mora IM, Silveira LH, Zazueta-Montiel BE, Castillo-Ortiz AA, Martínez A, Zamora-Tehozol E, Maya-Piña LV, Perez-Barbosa L, Galarza-Delgado DA, Hernandez MDC, Marquez-Miranda O, Andrade-Ortega L, Fuentes-Hernandez MN, Morales DV, Aguiar MC, Oostdam DAH, Loredo-Alanis SA, Martín-Nares E, Durán-Barragán S, Jiménez-Jiménez X, Vázquez-Del Mercado M, Moctezuma-Rios JF, Rull-Gabayet M, Barragán-Garfías JA, Tena CFP, Xibille-Friedmann DX, Alpizar-Rodriguez D; Mexican Study Group of COVID-19 in Rheumatic Diseases. Martínez-Martínez MU, et al. Among authors: tena cfp. J Clin Rheumatol. 2024 May 16. doi: 10.1097/RHU.0000000000002086. Online ahead of print. J Clin Rheumatol. 2024. PMID: 38753050 No abstract available.
Continuing versus withdrawing ixekizumab treatment in patients with axial spondyloarthritis who achieved remission: efficacy and safety results from a placebo-controlled, randomised withdrawal study (COAST-Y).
Landewé RB, Gensler LS, Poddubnyy D, Rahman P, Hojnik M, Li X, Liu Leage S, Adams D, Carlier H, Van den Bosch F; COAST-Y study group. Landewé RB, et al. Ann Rheum Dis. 2021 Aug;80(8):1022-1030. doi: 10.1136/annrheumdis-2020-219717. Epub 2021 May 6. Ann Rheum Dis. 2021. PMID: 33958326 Free PMC article. Clinical Trial.
Withdrawing Ixekizumab in Patients With Psoriatic Arthritis Who Achieved Minimal Disease Activity: Results From a Randomized, Double-Blind Withdrawal Study.
Coates LC, Pillai SG, Tahir H, Valter I, Chandran V, Kameda H, Okada M, Kerr L, Alves D, Park SY, Adams DH, Gallo G, Hufford MM, Hojnik M, Mease PJ, Kavanaugh A; SPIRIT-P3 Study Group. Coates LC, et al. Arthritis Rheumatol. 2021 Sep;73(9):1663-1672. doi: 10.1002/art.41716. Epub 2021 Aug 6. Arthritis Rheumatol. 2021. PMID: 33682378 Free PMC article.
Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial.
Deodhar A, van der Heijde D, Gensler LS, Kim TH, Maksymowych WP, Østergaard M, Poddubnyy D, Marzo-Ortega H, Bessette L, Tomita T, Leung A, Hojnik M, Gallo G, Li X, Adams D, Carlier H, Sieper J; COAST-X Study Group. Deodhar A, et al. Lancet. 2020 Jan 4;395(10217):53-64. doi: 10.1016/S0140-6736(19)32971-X. Epub 2019 Dec 5. Lancet. 2020. PMID: 31813637 Clinical Trial.
Efficacy and safety of tregalizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase IIb, randomised, placebo-controlled trial.
van Vollenhoven RF, Keystone EC, Strand V, Pacheco-Tena C, Vencovský J, Behrens F, Racewicz A, Zipp D, Rharbaoui F, Wolter R, Knierim L, Schmeidl R, Zhou X, Aigner S, Dälken B, Wartenberg-Demand A; TREAT2b study team. van Vollenhoven RF, et al. Ann Rheum Dis. 2018 Apr;77(4):495-499. doi: 10.1136/annrheumdis-2017-212478. Epub 2018 Jan 17. Ann Rheum Dis. 2018. PMID: 29343509 Clinical Trial.
13 results